Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax' Global Production Capacity to Over 2 Billion Doses Annually
Stock Information for Novavax Inc.
Loading
Please wait while we load your information from QuoteMedia.